Company Overview and News

1
Nomination de Nicolas Huss au poste de COO Groupe

2018-07-13 globenewswire
Philippe Lazare, Président-directeur général d'Ingenico Group, nomme Nicolas Huss au poste de Chief Operating Officer (COO). Cette nouvelle fonction accélèrera la mise en cohérence des offres et l'efficacité commerciale du Groupe.
APO.PRB APO.PRA INGIF APO ING INGIY

1
Appointment of Nicolas Huss as Ingenico Group COO

2018-07-13 globenewswire
Philippe Lazare, Chairman and Chief Executive Officer of Ingenico Group, appoints Nicolas Huss as Chief Operating Officer (COO). This new function will maximise the effectiveness and efficiency of the Group's business operations.
APO.PRB APO.PRA INGIF APO ING INGIY

0
INGENICO GROUP: Q2 and Half-Year 2018 Results Conference Call

2018-07-10 globenewswire
A press release and a presentation will be available on www.ingenico.com prior to the call at (5:40pm).
INGIF ING INGIY

0
INGENICO GROUP : Informations relatives au nombre total de droits de vote et d'actions composant le capital au 30 juin 2018

2018-07-03 globenewswire
INGENICO GROUP Société Anonyme au capital de 63.144.527 euros Siège social : 28/32 boulevard de Grenelle 75015 Paris RCS Paris : 317 218 758
INGIF ING INGIY

0
INGENICO GROUP : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE

2018-07-03 globenewswire
INGENICO GROUP Société Anonyme au capital de 63 144 527 euros Siège social : 28/32 boulevard de Grenelle 75015 Paris RCS Paris : 317 218 758
INGIF ING INGIY

0
INGENICO GROUP: Ingenico's Axium D7 first POS to achieve both Google Mobile Services and PCI-PTS v5 certifications

2018-06-28 globenewswire
Ingenico Group (Euronext: FR0000125346 - ING), the global leader in seamless payment, today announced that its Axium D7, the world's only payment device to fulfil the Google Mobile Services (GMS) requirements, achieved the PCI-PTS v5 certification, highest security standard in the payment industry. This makes the Axium D7 unique on two grounds.
INGIF ING INGIY

0
INGENICO GROUP : L'Axium D7 d'Ingenico premier terminal à recevoir les certifications Google Mobile Services et PCI-PTS v5

2018-06-28 globenewswire
Ingenico Group (Euronext : FR0000125346 - ING), leader mondial des solutions de paiement intégrées, a annoncé aujourd'hui que son terminal Axium D7 a reçu la certification PCI-PTS v5, la norme de sécurité la plus stricte du secteur des paiements. L'Axium D7 est également le premier terminal de paiement répondant aux exigences de Google Mobile Services (GMS). Il se démarque sur ces deux points.
INGIF ING INGIY

0
INGENICO GROUP: Result of the option to receive the 2017 dividend payment in shares

2018-06-18 globenewswire
Ingenico Group shareholders meeting held on May 16, 2018 in Paris, has approved the proposed dividend, related to the 2017 fiscal year, of 1.60 euro per share and has decided to offer each shareholder the possibility to receive the dividend in cash or in shares.
INGIF ING INGIY

0
INGENICO GROUP : Résultat de l'option pour le paiement du dividende 2017 en actions

2018-06-18 globenewswire
L'assemblée générale des actionnaires Ingenico Group, réunie le 16 mai 2018 à Paris, a approuvé le dividende proposé au titre de l'exercice 2017, soit 1,60 euro par action, et a décidé que chaque actionnaire pourrait choisir de recevoir le paiement du dividende en numéraire ou en actions.
INGIF ING INGIY

0
INGENICO GROUP : Informations relatives au nombre total de droits de vote et d'actions composant le capital au 31 mai 2018

2018-06-05 globenewswire
INGENICO GROUP Société Anonyme au capital de 62.363.114 euros Siège social : 28/32 boulevard de Grenelle 75015 Paris RCS Paris : 317 218 758
INGIF ING INGIY

0
Ingenico Group entre en négociations exclusives avec Sparkassen-Finanzgruppe pour combiner BS PAYONE avec les actifs DACH d'Ingenico Retail

2018-05-30 globenewswire
Ingenico Group (Euronext: FR0000125346 - ING), leader mondial des solutions de paiement intégrées, annonce aujourd'hui entrer en négociations exclusives en vue de combiner BS PAYONE, détenu par DSV (filiale de Sparkassen-Finanzgruppe), avec les actifs Retail d'Ingenico Group dans la région DACH (Allemagne, Autriche et Suisse). Cette combinaison d'actifs, qui n'intègre pas de composante en numéraire, sera détenue à 52% et consolidée par Ingenico Group.
INGIF ING INGIY

0
Ingenico Group enters into exclusive negotiations with Sparkassen-Finanzgruppe to combine BS PAYONE with Ingenico Retail assets in DACH

2018-05-30 globenewswire
Ingenico Group, (Euronext: FR0000125346 - ING), the global leader in seamless payment, today announced it entered into exclusive negotiations regarding the combination of BS PAYONE owned by DSV (a subsidiary of the Sparkassen-Finanzgruppe) with Ingenico Retail assets in DACH (Germany, Austria, Switzerland). This non-cash business combination would be 52% owned and consolidated by Ingenico Group.
INGIF ING INGIY

0
L'Axium D7 d'Ingenico Group certifié Google Mobile Services : une première mondiale dans l'industrie du paiement

2018-05-29 globenewswire
Ingenico Group (Euronext : FR0000125346-ING), leader mondial des solutions de paiement intégrées, a annoncé aujourd'hui que sa solution de paiement et d'encaissement Axium D7 a reçu la certification Google Mobile Services (GMS). L'Axium D7 devient ainsi le premier terminal sécurisé répondant aux exigences GMS et capable d'exécuter les applications Google.
INGIF ING INGIY

0
Ingenico Group achieves a world first in the payment industry with the Google Mobile Services certification of its Axium D7

2018-05-29 globenewswire
Ingenico Group (Euronext: FR0000125346-ING), the global leader in seamless payment, today announced that its Axium D7 ECR-POS has achieved Google Mobile Services certification, making it the world's first secure POS terminal to meet GMS requirements and properly run applications by Google.
INGIF ING INGIY

0
INGENICO GROUP : Assemblée Générale Mixte annuelle - Résultats des votes

2018-05-16 globenewswire
Ingenico Group (Euronext : FR0000125346 - ING), leader mondial des solutions de paiement intégrées, a tenu aujourd'hui son Assemblée Générale Mixte à Paris.
INGIF ING INGIY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EPA:ING / INGENICO GROUP on message board site Silicon Investor.

Income Investing Tell a joke - anything goes
Zman Market Timing Computer Learning
Mining News of Note Qualcomm Moderated Thread - please read rules before posting
ASML Holding NV Inventus Mining Corp - IVS
McEwen Mining Value Investing